文献速递真菌感染

氟康唑拖尾效应对氟康唑治疗白色念珠菌血流感染持续性的影响

The impact of the fluconazole trailing effect on the persistence of Candida albicans bloodstream infection when treated with fluconazole.
PubMed 文献 · Clin Microbiol Infect · 2024-03-23

该研究回顾性分析台湾南部三家医院2013至2020年190例氟康唑敏感白色念珠菌血流感染患者,按EUCAST法将拖尾程度分为残留、轻度、中度、重度。结果显示48小时重度拖尾组持续念珠菌血症比例高于非重度拖尾组(13.3% vs 1.4%,p=0.007),多因素分析显示重度拖尾、免疫抑制和住院天数为持续念珠菌血症独立因素。

要点

  • 48小时重度拖尾组持续念珠菌血症比例为13.3%(16/120),非重度拖尾组为1.4%(1/70),p=0.007。
  • 多因素分析显示免疫抑制(OR=7.92)、住院天数(OR=1.03)和48小时重度拖尾(OR=10.04)为持续念珠菌血症独立因素。
  • 190例中持续念珠菌血症17例(8.9%),24、48、72小时重度拖尾比例分别为63.7%、63.2%、74.7%。

核心结论

  • 本研究表明,在接受氟康唑治疗的白色念珠菌血流感染患者中,分离株重度拖尾与持续念珠菌血症相关。

研究设计与样本

  • 回顾性研究,纳入台湾南部三家医院2013年至2020年因氟康唑敏感白色念珠菌血流感染接受氟康唑治疗的患者,共190例分离株。
  • 采用EUCAST法测定拖尾程度,按平均生长高于MIC除以最低药物浓度下测得生长分类:残留(0.1-5%)、轻度(6-10%)、中度(11-15%)、重度(>15%)。

主要发现

  • 190例分离株中,24、48、72小时重度拖尾比例分别为63.7%(121/190)、63.2%(120/190)、74.7%(142/190)。
  • 持续念珠菌血症见于17例(8.9%)患者。
  • 48小时重度拖尾组持续白色念珠菌血症比例为13.3%(16/120),非重度拖尾组为1.4%(1/70),p=0.007。
  • 多因素分析显示免疫抑制(OR=7.92;95% CI:2.38-26.39,p=0.001)、白色念珠菌鉴定索引日期后住院天数(OR=1.03;95% CI:1.01-1.05,p=0.011)和48小时重度拖尾分离株(OR=10.04;95% CI:1.27-79.88,p=0.029)为持续念珠菌血症独立因素。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The trailing effect of Candida species is a phenomenon characterized by reduced but persistent growth at antifungal concentrations above the MIC. We assessed the impact of trailing growth on the persistence of Candida albicans candidemia in patients receiving fluconazole (FLC) therapy. METHODS: We retrospectively investigated candidemia isolates at three hospitals in southern Taiwan between 2013 and 2020. Patients treated with FLC for FLC-susceptible C. albicans candidemia were enrolled. The degree of trailing was determined as the average growth above the MIC divided by the measured growth at the lowest drug concentration using the EUCAST method and classified into four categories: residual (0.1-5%), slight (6-10%), moderate (11-15%), and heavy trailers (>15%). RESULTS: Among isolates from 190 patients, the proportions of heavy trailers at 24 hours, 48 hours, and 72 hours were 63.7% (121/190), 63.2% (120/190), and 74.7% (142/190), respectively. Persistent candidemia was observed in 17 (8.9 %) patients. The proportion of persistent C. albicans candidemia in heavy trailing isolates at 48 hours was higher than in isolates without heavy trailing (13.3% [16/120] vs. 1.4% [1/70], p = 0.007). A multivariate analysis showed that immunosuppression (OR = 7.92; 95% CI: 2.38-26.39, p = 0.001), hospitalization days after the index date of C. albicans identification (OR = 1.03; 95% CI: 1.01-1.05, p = 0.011), and heavy trailing isolates at 48 hours (OR = 10.04; 95% CI: 1.27-79.88, p = 0.029) were independent factors for persistent candidemia. DISCUSSION: The current study revealed that heavy trailing in C. albicans isolates is associated with persistent candidemia in patients receiving FLC treatment.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Lin SY, Huang HY, Chang LL, et al. The impact of the fluconazole trailing effect on the persistence of Candida albicans bloodstream infection when treated with fluconazole. Clin Microbiol Infect. 2024. PMID: 38527614. doi:10.1016/j.cmi.2024.03.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。